Dr. Martens Plc (GB:DOCS)
LSE:DOCS
Holding GB:DOCS?
Track your performance easily

Dr. Martens Plc (DOCS) Share Forecast & Price Target

113 Followers
See the Price Targets and Ratings of:

DOCS Analyst Ratings

Hold
2Ratings
0 Buy
2 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Dr.
Martens Plc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DOCS Stock 12 Month Forecast

Average Price Target

82.50p
▲(46.93% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Dr. Martens Plc in the last 3 months. The average price target is 82.50p with a high forecast of 85.00p and a low forecast of 80.00p. The average price target represents a 46.93% change from the last price of 56.15p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"54":"54p","87":"87p","120":"120p","70.5":"70.5p","103.5":"103.5p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">85.00p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">82.50p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">80.00p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[54,70.5,87,103.5,120],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.85,58.09230769230769,60.33461538461539,62.57692307692308,64.81923076923077,67.06153846153846,69.30384615384615,71.54615384615384,73.78846153846155,76.03076923076924,78.27307692307693,80.51538461538462,82.75769230769231,{"y":85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.85,57.9,59.95,62,64.05,66.1,68.15,70.2,72.25,74.3,76.35,78.4,80.45,{"y":82.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,55.85,57.70769230769231,59.565384615384616,61.42307692307693,63.28076923076923,65.13846153846154,66.99615384615385,68.85384615384615,70.71153846153847,72.56923076923077,74.42692307692307,76.28461538461539,78.1423076923077,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":119.36,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":92.52,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":83.21,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":82.76,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":95.44,"date":1709251200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":91.74,"date":1712275200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":79.8,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":84.2,"date":1717718400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":73.59,"date":1720137600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":67.42,"date":1722556800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":67.5,"date":1725580800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":56.55,"date":1728000000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":55.85,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target85.00pAverage Price Target82.50pLowest Price Target80.00p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
87p70p
Sell
24.67%
Upside
Reiterated
05/31/24
Dr. Martens Plc (DOCS.L): In-line FY24; FY25 year of transition with cost saving action; remain 2024 | 7:08AM BST FY24 sales slightly below expectations, but EBITDA in line and FY25 sales outlook 2H weighted. This morning (May 30), Dr. Martens released FY24 earnings (post a Q4 trading update on April 16th) and reported adjusted EBITDA of £197.5mn (in line with company guidance and consensus) with FY24 EBITDA margins decreasing 200bps yoy to 13.9%. In addition, Dr. Martens commented on current trading and confirmed performance is in line with their expectations. They now expect revenue decline of -20% cFX in 1H25 driven by wholesale, which is expected to decline by a third in the period driven by weak order book and excess inventory in the channel.
Deutsche Bank
0.65p75p
Hold
33.57%
Upside
Reiterated
05/31/24
Dr. Martens Plc (DOCS:LN) PT Raised to GBP0.75 at Deutsche BankDeutsche Bank analyst Alison Lygo raised the price target on Dr. Martens Plc (DOCS:LN) to GBP0.75 (from GBP0.65) while maintaining a Hold rating.
HSBC
95p70p
Hold
24.67%
Upside
Reiterated
04/26/24
Dr. Martens Plc (DOCS:LN) PT Lowered to GBP0.70 at HSBCHSBC analyst Doriana Russo lowered the price target on Dr. Martens Plc (DOCS:LN) to GBP0.70 (from GBP0.95) while maintaining a Hold rating.
Morgan Stanley
75p
Hold
33.57%
Upside
Reiterated
04/16/24
We think investors will be surprised by the extent of the downgrade, despite the series of guide downs the company has given over the past 18 months. We expect consensus to significantly de-risk 2025 forecasts on the back of the news, even with the company pointing to their guidance as a "worse case scenario". We cut our numbers in line with their worse case scenario guidance.

Best Analysts Covering Dr. Martens Plc

Which Analyst Should I Follow If I Want to Buy GB:DOCS and Sell After:
1 Month
xxx
Success Rate
2/5 ratings generated profit
40%
Average Return
-1.16%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -1.16% per trade.
3 Months
xxx
Success Rate
2/5 ratings generated profit
40%
Average Return
-6.76%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -6.76% per trade.
1 Year
Louise SinglehurstGoldman Sachs
Success Rate
3/5 ratings generated profit
60%
Average Return
-2.36%
reiterated a sell rating 5 months ago
Copying Louise Singlehurst's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -2.36% per trade.
2 Years
xxx
Success Rate
3/5 ratings generated profit
60%
Average Return
-8.04%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of -8.04% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DOCS Analyst Recommendation Trends

Rating
Apr 24
May 24
Jun 24
Sep 24
Oct 24
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
9
7
8
5
5
Sell
2
3
2
1
0
Strong Sell
0
0
0
0
0
total
11
10
10
6
5
In the current month, DOCS has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. DOCS average Analyst price target in the past 3 months is 82.50p.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

DOCS Financial Forecast

DOCS Earnings Forecast

Next quarter’s earnings estimate for DOCS is -0.05p with a range of -0.05p to -0.05p. The previous quarter’s EPS was 0.05p. DOCS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.11% of the time in the same period. In the last calendar year DOCS has Underperformed its overall industry.
Next quarter’s earnings estimate for DOCS is -0.05p with a range of -0.05p to -0.05p. The previous quarter’s EPS was 0.05p. DOCS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.11% of the time in the same period. In the last calendar year DOCS has Underperformed its overall industry.

DOCS Sales Forecast

Next quarter’s sales forecast for DOCS is 313.05M with a range of 313.05M to 313.05M. The previous quarter’s sales results were 481.30M. DOCS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 63.41% of the time in the same period. In the last calendar year DOCS has Underperformed its overall industry.
Next quarter’s sales forecast for DOCS is 313.05M with a range of 313.05M to 313.05M. The previous quarter’s sales results were 481.30M. DOCS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 63.41% of the time in the same period. In the last calendar year DOCS has Underperformed its overall industry.

DOCS Stock Forecast FAQ

What is GB:DOCS’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Martens Plc’s 12-month average price target is 82.50p.
    What is GB:DOCS’s upside potential, based on the analysts’ average price target?
    Dr. Martens Plc has 46.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Dr. Martens Plc a Buy, Sell or Hold?
          Dr. Martens Plc has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Dr. Martens Plc’s share price target?
            The average share price target for Dr. Martens Plc is 82.50p. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is 85.00p ,and the lowest forecast is 80.00p. The average share price target represents 46.93% Increase from the current price of 56.15p.
              What do analysts say about Dr. Martens Plc?
              Dr. Martens Plc’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Dr. Martens Plc?
                To buy shares of GB:DOCS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis